CN1280290C - 新型吡喃糖苷葡萄糖及其离析方法与含有此物质的药用组合物及其用法 - Google Patents

新型吡喃糖苷葡萄糖及其离析方法与含有此物质的药用组合物及其用法 Download PDF

Info

Publication number
CN1280290C
CN1280290C CNB028291042A CN02829104A CN1280290C CN 1280290 C CN1280290 C CN 1280290C CN B028291042 A CNB028291042 A CN B028291042A CN 02829104 A CN02829104 A CN 02829104A CN 1280290 C CN1280290 C CN 1280290C
Authority
CN
China
Prior art keywords
glucopyranoside
hydroxyphenylbenzofuran
hydroxy
extract
general formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB028291042A
Other languages
English (en)
Chinese (zh)
Other versions
CN1633432A (zh
Inventor
拉凯什·毛拉
迪帕·辛格
阿沙·巴格特
奥姆·帕卡什·古普塔
苏克德夫·斯瓦米·汉达
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Council of Scientific and Industrial Research CSIR
Original Assignee
Council of Scientific and Industrial Research CSIR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Council of Scientific and Industrial Research CSIR filed Critical Council of Scientific and Industrial Research CSIR
Publication of CN1633432A publication Critical patent/CN1633432A/zh
Application granted granted Critical
Publication of CN1280290C publication Critical patent/CN1280290C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/06—Heterocyclic radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
CNB028291042A 2002-04-08 2002-04-08 新型吡喃糖苷葡萄糖及其离析方法与含有此物质的药用组合物及其用法 Expired - Fee Related CN1280290C (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2002/000105 WO2003087093A1 (en) 2002-04-08 2002-04-08 Novel glucopyranoside, process for isolation thereof, pharmaceutical composition containing same and use thereof

Publications (2)

Publication Number Publication Date
CN1633432A CN1633432A (zh) 2005-06-29
CN1280290C true CN1280290C (zh) 2006-10-18

Family

ID=29227416

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB028291042A Expired - Fee Related CN1280290C (zh) 2002-04-08 2002-04-08 新型吡喃糖苷葡萄糖及其离析方法与含有此物质的药用组合物及其用法

Country Status (7)

Country Link
EP (1) EP1495019B1 (enExample)
JP (1) JP4309769B2 (enExample)
CN (1) CN1280290C (enExample)
AT (1) ATE399778T1 (enExample)
AU (1) AU2002246317A1 (enExample)
DE (1) DE60227421D1 (enExample)
WO (1) WO2003087093A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2567571T3 (es) * 2003-03-14 2016-04-25 Astellas Pharma Inc. Derivados de C-glucósido y sales de los mismos
TW200524951A (en) 2003-08-01 2005-08-01 Janssen Pharmaceutica Nv Substituted benzimidazole-, benztriazole-, and benzimidazolone-O-glucosides
CA2549015A1 (en) 2003-08-01 2005-02-10 Janssen Pharmaceutica N.V. Substituted fused heterocyclic c-glycosides
AU2004261264A1 (en) 2003-08-01 2005-02-10 Janssen Pharmaceutica N.V. Substituted indazole-O-glucosides
TW200526678A (en) 2003-08-01 2005-08-16 Janssen Pharmaceutica Nv Substituted indole-O-glucosides
EP1721904A4 (en) * 2004-03-04 2010-07-14 Kissei Pharmaceutical HETEROCYCLIC DERIVED FADE; MEDICAL COMPOSITION CONTAINING THE DERIVATIVE AND MEDICAL USE
RU2387663C2 (ru) * 2004-03-04 2010-04-27 Киссеи Фармасьютикал Ко., Лтд. Конденсированные гетероциклические производные, содержащие их медицинские композиции и их медицинское применение
EP2105442A4 (en) 2006-12-21 2013-01-23 Astellas Pharma Inc PROCESS FOR PREPARING A C-GLYCOSIDE DERIVATIVE AND SYNTHETIC INTERMEDIATE PRODUCT THEREFOR
TW201623321A (zh) * 2014-05-13 2016-07-01 韓美藥品股份有限公司 雙環衍生物及包含其之藥學組成物
CN106674311B (zh) * 2016-12-27 2019-02-05 西安交通大学 一种苯并呋喃苷类化合物及其制备方法和应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6627611B2 (en) * 2000-02-02 2003-09-30 Kotobuki Pharmaceutical Co Ltd C-glycosides and preparation of thereof as antidiabetic agents

Also Published As

Publication number Publication date
JP4309769B2 (ja) 2009-08-05
ATE399778T1 (de) 2008-07-15
JP2005528398A (ja) 2005-09-22
AU2002246317A1 (en) 2003-10-27
EP1495019A1 (en) 2005-01-12
WO2003087093A1 (en) 2003-10-23
CN1633432A (zh) 2005-06-29
EP1495019B1 (en) 2008-07-02
DE60227421D1 (de) 2008-08-14

Similar Documents

Publication Publication Date Title
US6562791B1 (en) Glucopyranoside, process for isolation thereof, pharmaceutical composition containing same and use thereof
US6617313B1 (en) Glucopyranoside and process of isolation thereof from pterocarpus marsupium pharmaceutical composition containing the same and use thereof
CN1219787C (zh) 8－（C－β－D－葡糖吡喃基）－7，3’，4’－三羟基黄酮、其分离方法、药物组合物和用于糖尿病治疗的方法
CN1280290C (zh) 新型吡喃糖苷葡萄糖及其离析方法与含有此物质的药用组合物及其用法
CA1288771C (en) Pseudopterosin and synthetic derivatives thereof
CN112592328A (zh) 草豆蔻中二芳基庚烷-查尔酮聚合物及其药物组合物与应用
CN1251698C (zh) 一种治疗内毒素血症的板蓝根提取物和用途
CN101074223B (zh) 芹菜素衍生物及其治疗糖尿病及并发症的用途
CN1286455C (zh) 5－羟甲基糠醛的药物用途
CN101134041B (zh) 抗抑郁药物及其应用
JP3943082B2 (ja) ８‐（ｃ‐β‐Ｄ‐グルコピラノシル）‐７，３’，４’‐トリヒドロキシフラヴォンの分子構造を有する物質、及びその分離方法とそれを用いた薬物組成
CN1417218A (zh) 山奈酚衍生物及其医药用途
EP0675895A1 (fr) Derives de l'etoposide, leur procede de preparation, leur utilisation a titre de medicament et leur utilisation pour la preparation d'un medicament destine au traitement anticancereux.
CN114533719A (zh) 松香烷型二萜类化合物在制备抗炎药物中的应用
CN100577176C (zh) 短瓣金莲花提取物、其抗炎有效成分和它们的用途
CN118206596B (zh) 一种飞蓬酸及其提取方法和应用、治疗缺血性脑中风的药物
CN1286469C (zh) 异落叶松树脂醇的药物用途
CN110218208B (zh) 一种狄尔斯-阿尔德型化合物及其制备方法和应用
CN1111527C (zh) 抗消化道溃疡的倍半萜内酯类化合物
CN118909025A (zh) 一种异海绵烷二萜化合物、其药物组合物及其制备方法和应用
CN117659105A (zh) 一种愈创木烷型倍半萜苷单体化合物及其制备方法和用途
CA2631127A1 (en) Biologically active compounds
CN119350408A (zh) 一种二氢异香豆素类化合物及其制备方法与应用
KR100516648B1 (ko) 리그난 화합물 및 이 물질을 유효성분으로 함유하는 당뇨병 치료제
CN117298123A (zh) 一类胆甾醇衍生物在制备糖尿病药物中的应用

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20061018

Termination date: 20120408